Aukrust P, Ueland T, Mller F, Andreassen AK, Nordy I, Aas H, Kjekshus J, Simonsen S, Frland SS, Gullestad L
Neuromuscular blockade The use of NMB in patients with moderate to severe ARDS has the potential benefit of decreasing ventilator-associated lung injury and improving mortality at 28 days without increasing the incidence of neuromuscular weakness
The Journal of Pharmacy Technology: JPT: Official Publication of the Association of Pharmacy Technicians, 38 (5), 283288
A qualified healthcare provider should interpret any genetic findings alongside your medical history, BMI, comorbidities, and treatment goals to recommend the most appropriate program and medication
Handling is restricted to qualified professionals
This is great news for anyone working closely with their primary care doctor to create a comprehensive healthcare plan